BASF Weighs Fresh Evonik Bid as Job Pledges Face Scrutiny Over Added Value
Published on 11/18/2026 at 02:51 | Editorial boerse-global.deBASF is sounding out political leaders and the RAG-Stiftung over a package of employment and site guarantees designed to revive its stalled pursuit of Evonik, according to reports from Reuters and Bloomberg. The crux is not the headline price. Any new commitments would have to go meaningfully beyond what BASF has already promised to shift the resistance that sank its earlier approach — and on that score, doubts are mounting.
A letter sent to North Rhine-Westphalia's state government and to the RAG-Stiftung, Evonik's largest shareholder, sketches possible pledges on sites, jobs and apprenticeships, Reuters reported. The draft still carries placeholders for timeframes and investment sums, leaving the key economic terms unresolved. Bloomberg added that BASF could rule out compulsory redundancies for a period still to be negotiated and commit to keeping all German production sites, alongside spending on research and development and on the climate-friendly conversion of its plants. A sweetened takeover offer could follow within days, though its size is unknown.
The groundwork has already been laid once. At the end of October, BASF pledged to take over Evonik's employment guarantees through 2032, keep the Marl and Wesseling chemical parks running with roughly 3,500 jobs, and preserve Essen as a key location. A draft dated 11 November, reported by Handelsblatt, would continue those existing employee commitments and add a board-level division based in Essen with responsibility for more than EUR 10 billion in revenue.
Insiders See Little Beyond the Status Quo
That is precisely where the plan looks thin. People familiar with the matter told Handelsblatt the draft contains hardly any material concessions beyond existing pledges. Evonik works council chief Hussin El Moussaoui made the same point, arguing that merely extending the status quo creates no added value. More pages, in other words, would not amount to a better offer.
Evonik has already turned down a cash bid worth more than EUR 11 billion, or EUR 24 per share. A fresh approach would therefore need to deliver more than a rewording of terms already on the table — and the support of the RAG-Stiftung, whose backing would carry particular weight, is far from assured.
Should investors sell immediately? Or is it worth buying BASF?
BASF has been courting lawmakers as well as the foundation. Chief executive Markus Kamieth and Evonik interim boss Claus Rettig met with their finance chiefs a few days ago, and IG BCE head Michael Vassiliadis broadly supports the initiative. Those are openings for dialogue, not an Evonik endorsement or an acceptance by the RAG-Stiftung.
The Trade-Off Between Concessions and Price Discipline
For BASF, the dilemma cuts both ways. Deeper guarantees could ease the path to approval, yet binding job and site commitments can curb savings from staff cuts or consolidation — and that in turn caps the takeover price that makes economic sense. A higher offer alone would not tell the full story; investors also need the duration of any guarantees and firm investment figures, neither of which is settled.
The stock offered a cautionary signal on Tuesday, with BASF shares down 2.9%. The decline came in a weak European session, though, so it cannot be pinned solely on the possible bid.
It is also worth keeping separate threads apart. An internal Evonik letter setting out demands on future owners concerned planned divestments, not a negotiated set of conditions for a BASF takeover. Reading it as a sign of rapprochement would overstate where the talks actually stand.
What Would Signal Real Progress
Until BASF firms up support and the core terms are locked down, the deal remains a possibility rather than a settled growth step. A more favorable read would be justified if binding commitments win visible backing while staying economically defensible. If price discipline or acceptance gives way instead, another attempt would leave the central doubts intact.
The next concrete catalyst is an offer actually on the table. Bloomberg suggests one could arrive within days, though no confirmed publication date exists. Investors should then weigh the purchase price, the binding nature of the pledges and the reaction of the decisive players as a single package — only that combination will show whether BASF is closing in on a deal or merely reshuffling the terms of a still-contested plan. Both companies declined to comment to Dow Jones.
Ad
BASF Stock: New Analysis - 18 November
Fresh BASF information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
